Skip to main content

Chronic Pain News (Page 3)

New Form of Psychotherapy Might Help Ease Chronic Pain

FRIDAY, June 14, 2024 – A new form of psychotherapy appears to work even better at treating chronic pain in older adults than gold-standard cognitive behavioral therapy (CBT), a new study finds....

Exercise + Pain Education No Boost for Chronic Pain After Knee Replacement

WEDNESDAY, May 29, 2024 – Neuromuscular exercise and pain neuroscience education do not provide superior pain and function outcomes versus pain neuroscience education alone in patients with chronic...

FDA Approves Arymo ER (morphine sulfate) Abuse-Deterrent Formulation for the Treatment of Chronic Pain

WAYNE, Penn., Jan. 9, 2017 /PRNewswire/ – Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing...

FDA Approves Belbuca (buprenorphine) Buccal Film for Chronic Pain Management

DUBLIN and RALEIGH, N.C., October 26, 2015 – Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc. (NASDAQ: BDSI),...

FDA Approves Targiniq ER Extended-Release Oxycodone with Abuse-Deterrent Properties

July 23, 2014 – Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Pain

Related drug support groups

gabapentin, tramadol, Cymbalta, ibuprofen, oxycodone, hydrocodone, naproxen, acetaminophen, amitriptyline, view more... Percocet, pregabalin, duloxetine, diclofenac, methadone, codeine, OxyContin, fentanyl, morphine, buprenorphine, nortriptyline, Butrans, Dilaudid, Roxicodone, Percocet 10/325, hydromorphone, Belbuca